We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

94 hedge funds and large institutions have $217M invested in Dianthus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.24% less ownership

Funds ownership: 4.39% → 4.14% (-0.24%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

1% less funds holding

Funds holding: 95 → 94 (-1)

12% less capital invested

Capital invested by funds: $248M → $217M (-$30.4M)

97% less call options, than puts

Call options by funds: $3K | Put options by funds: $89K

Holders
94
Holders Change
-1
Holders Change %
-1.05%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
34
Reduced
16
Closed
18
Calls
$3K
Puts
$89K
Net Calls
-$86K
Net Calls Change
+$27K

Top Buyers

1
ACM
Aquilo Capital Management
California
+$7.1M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.38M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.3M
4
BlackRock
BlackRock
New York
+$1.23M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.13M

Top Sellers

1
Alkeon Capital Management
Alkeon Capital Management
New York
-$4.51M
2
AG
Artal Group
Luxembourg
-$3.38M
3
EC
EcoR1 Capital
California
-$3.38M
4
CH
CVI Holdings
Delaware
-$3.11M
5
LM
Luminus Management
Texas
-$2.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
51
Bollard Group
Massachusetts
$190K – – –
Arrowstreet Capital
52
Arrowstreet Capital
Massachusetts
$183K +$102K +860 +105%
Cerity Partners
53
Cerity Partners
New York
$177K – – –
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$136K -$12.2K -103 -8%
OC
55
Oppenheimer & Co
New York
$136K – – –
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
$130K +$142K +1,199 New
Prudential Financial
57
Prudential Financial
New Jersey
$128K +$139K +1,176 New
EW
58
Evoke Wealth
California
$123K – – –
PC
59
PA Capital
Virginia
$109K +$37.6K +317 +46%
CSS
60
Cubist Systematic Strategies
Connecticut
$94K +$102K +865 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$85K +$6.28K +53 +7%
AIG
62
American International Group
New York
$84K +$14.9K +126 +19%
AWM
63
Aries Wealth Management
Maine
$82K – – –
EGM
64
Engineers Gate Manager
New York
$82K +$89.6K +756 New
Wells Fargo
65
Wells Fargo
California
$81K -$118 -1 -0.1%
Deutsche Bank
66
Deutsche Bank
Germany
$79K +$19.1K +161 +29%
ProShare Advisors
67
ProShare Advisors
Maryland
$70K +$76.3K +644 New
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$69K – – –
TRCT
69
Tower Research Capital (TRC)
New York
$49K -$6.28K -53 -11%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$34K – – –
Citigroup
71
Citigroup
New York
$34K +$2.73K +23 +8%
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$33.1K +$31.2K +263 +641%
Federated Hermes
73
Federated Hermes
Pennsylvania
$29K – – –
CAPTRUST Financial Advisors
74
CAPTRUST Financial Advisors
North Carolina
$28K – – –
Simplex Trading
75
Simplex Trading
Illinois
$26K +$25.2K +213 +761%
1 2
3
4 5

DNTH Hedge Fund Activity: Q3 2020 in Review

94 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q3 2020, worth a combined $217M — down 12% from $248M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of DNTH and 17 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 34 added.

The largest buyer was Aquilo Capital Management, opening a new position worth an estimated $7.1M. The largest seller was Alkeon Capital Management, exiting entirely with an estimated $4.51M sold.

  • 94 institutional investors held Dianthus Therapeutics (DNTH) as of Q3 2020, down from 95 in Q2 2020.
  • Funds reported $217M of Dianthus Therapeutics stock for Q3 2020, down 12% quarter-over-quarter.
  • 17 funds opened new Dianthus Therapeutics positions in Q3 2020 and 18 closed out, a net change of -1 holder.
  • The largest Dianthus Therapeutics buyer in Q3 2020 was Aquilo Capital Management, an estimated $7.1M added.
  • The largest Dianthus Therapeutics seller in Q3 2020 was Alkeon Capital Management, an estimated $4.51M sold.

Based on aggregated 13F filings for Q3 2020.